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Abstract Germinomas arising in the sella turcica are
difﬁcult to differentiate from autoimmune hypophysitis
because of similar clinical and pathological features. This
differentiation, nevertheless, is critical for patient care due
to different treatments of the two diseases. We report the
case of an 11-year-old girl who presented with diabetes
insipidus and growth retardation, and was found to have
an intra- and supra-sellar mass. Initial examination of the
pituitary biopsy showed diffuse lymphocytic inﬁltration of
the adenohypophysis and absent placental alkaline phos-
phatase expression, leading to a diagnosis of hypophysitis
and glucocorticoid treatment. Because of the lack of clinical
and radiological response, the pituitary specimen was re-
examined, revealing this time the presence of scattered c-kit
and Oct4 positive germinoma cells. The revised diagnosis
prompted the initiation of radiotherapy, which induced
disappearance of the pituitary mass. Immunological studies
showed that the patient’s serum recognized antigens
expressed by the patient’s own germinoma cells, as well as
pituitary antigens like growth hormone and systemic anti-
gens like the Sjo ¨gren syndrome antigen B and alpha-eno-
lase. The study ﬁrst reports the presence of pituitary and
systemic antibodies in a patient with intrasellar germinoma,
and reminds us that diffuse lymphocytic inﬁltration of the
pituitary gland and pituitary antibodies does not always
indicate a diagnosis of autoimmune hypophysitis.
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Introduction
Germinomas of the brain are rare, representing between 0.4
and 3.4% of all primary intracranial tumors [1]. They affect
predominantly pre-pubertal children [2], and localize more
often to the pineal gland or the suprasellar region [2, 3],
although bifocal lesions are also described [4]. Clinically,
sellar germinomas present with a triad of diabetes insipi-
dus, hypopituitarism (most commonly GH deﬁciency), and
visual disturbances (both in acuity and ﬁelds). Serologi-
cally, germinomas of the brain are usually (85–90%)
negative for beta human chorionic gonadotropin (b-hCG)
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DOI 10.1007/s11102-009-0187-x[1] and alpha-fetoprotein. Pathologically, germinomas
feature a characteristic large cell having a centric nucleus
with one or more prominent nucleoli surrounded by a clear
and abundant cytoplasm (so-called fried-egg appearance).
In addition, these tumors contain numerous inﬁltrating
lymphocytes. In the majority (75%) of cases, inﬁltrating
lymphocytes are seen side-by-side to nests of neoplastic
cells, establishing a two-cell pattern. In the remaining
minority (25%), lymphocytes largely outnumber few iso-
lated neoplastic cells, which therefore become much more
difﬁcult to identify [5]. Sellar germinomas enter most
commonly in the differential diagnosis of suprasellar
masses, together with craniopharyngiomas, Rathke cleft
cysts, arachnoid cysts, pituitary adenomas, pituitary
metastasis, and Wegener granulomatosis. Occasionally,
sellar germinomas localize within the sella turcica and thus
enter in the differential of other pituitary lesions rich in
lymphocytes, such as lymphocytic hypophysitis.
Hypophysitis can be primary or secondary to systemic
or local lesions, such as Rathke’s cleft cyst, craniopha-
ryngioma, or germinoma [6]. Primary hypophysitis is
caused by an autoimmune reaction directed against the
pituitary gland, which becomes pathologically inﬁltrated
by lymphocytes. Primary lymphocytic or autoimmune
hypophysitis, abbreviated here as AH, is more common in
women during the fourth decade of life [6], but rare in
children. Only 25 cases have been reported in patients
\18 years old at the time of presentation [7].
During the past 10 years, nine cases of lymphocytic
hypophysitis secondary to a germinoma initially misdiag-
nosed as primary AH have been reported [8–16]. In some
patients, the initial diagnosis originated from a clinical and
radiological suspicion of hypophysitis, later disproved
upon pathological examination [13]. In other patients, a
germinoma was suspected clinically but the ﬁrst patho-
logical examination failed to reveal germinoma cells
because of the dense lymphocytic inﬁltrate [8–11, 16].
We report here an additional patient with an intra-sellar
and supra-sellar germinoma initially misdiagnosed and
treated for AH, and describe the immunological ﬁndings as
related to antibodies recognizing pituitary and extra-pitui-
tary antigens.
Case report
History and clinical examination
An 11-year-old girl was referred for blurred vision, fatigue,
polyuria and polydipsia of 18 months duration. Height and
body weight were at the 10th and 3rd percentile, respec-
tively, and no pubertal development (Tanner I) was present.
Her medical and family history was unremarkable.
Ophthalmological examination showed decreased visual
acuity and bitemporal inferior quadrantanopia with diffuse
bilateral optic pallor. Baseline assessment of pituitary
hormones revealed central hypothyroidism (low free T4
of 0.4 pmol/L with inappropriately normal TSH of 2.24
lIU/mL), decreased serum IGF-1 (34 ng/mL), and slightly
increased prolactin (23.2 ng/mL). Gonadotropins were
in the pre-pubertal range (LH\0.2 mIU/mL and
FSH\0.7 mIU/mL). Serum AFP (6.2 ng/mL) and b-hCG
(\0.2 mIU/mL) were negative. Serum cortisol rose only to
11.2 lg/dL after administration of 1 lg of ACTH, indicat-
ing a partial adrenal insufﬁciency. Serum and urine elec-
trolytes were normal. She was diagnosed with central
diabetes insipidus based on the clinical presentation and
response to DDAVP, and treated with desmopressin nasal
spray. Anterior pituitary hormones were replaced.
Neuroimaging studies
Cranial MRI (1.5 Tesla magnet) showed an intra- and
supra-sellar mass measuring 22 9 16 9 17 mm (Fig. 1a).
The mass compressed the optic chiasm, extended mini-
mally into the hypothalamus and down into the pituitary
with no visible posterior pituitary bright spot. The mass
was iso-hypointense on T1 and T2 weighted images, and
heterogeneous on T2 weighted images without cystic
components or focal areas of decreased signal suggestive
of calciﬁcation. The mass markedly enhanced after gado-
linium injection; it remained clearly distinct from the
cavernous sinuses, although caused a slight bowing of the
supraclinoid portion of both internal carotid arteries with
normal ﬂow void. No other abnormalities were identiﬁed.
Preoperatively, craniopharyngioma was the favored diag-
nosis, although germinoma and granulomatous entities
such as sarcoidosis were also included in the differential.
Pituitary surgery, pathology and postoperative course
A pituitary biopsy was obtained through a fronto-temporal
craniotomy approach. Pathological examination of the
biopsy showed an anterior pituitary lobe heavily inﬁltrated
by mononuclear cells, with extensive loss of the normal
endocrine cells and acinar architecture (Fig. 2a). Immu-
nostainings revealed an equal mixture of B (CD79 positive,
Fig. 2b) and T (CD3 positive, data not shown) lympho-
cytes, and absent placental alkaline phosphatase (PLAP) or
b-hCG expression (data not shown). No immunostainings
for c-Kit or Oct4 were performed because germinoma cells
were not evident, and thus germinoma was not suspected.
A diagnosis of AH was made and the patient began
immediately an intravenous steroid pulse therapy (meth-
ylprednisolone, 30 mg/kg over 2 h for 3 days), followed by
oral prednisone (2 mg/kg/day) for 2 weeks, tapering the
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123dose in 6 weeks. After such treatment, MRI showed only a
marginal decrease in the size of the mass (Fig. 1b), and
visual ﬁelds worsened rather than improved. The initial
diagnosis of AH was, thus, questioned, prompting a reex-
amination of the pituitary biopsy. This second pathological
analysis showed in the anterior pituitary single, large,
round cells with prominent nucleoli and abundant clear
cytoplasm (Fig. 2c), amongst the dense lymphoid inﬁltrate.
The diagnosis of germinoma was established by demon-
strating that these large cells were positive for c-Kit
(Fig. 2d) and Oct4 (data not shown).
Radiation therapy and follow-up
The girl was treated promptly with radiation therapy, using
the most conformal plan possible to spare the normal
adjacent brain. She received 25.2 Co Gy equivalent to the
ventricular region and then a cumulative dose of 41.4 Co
Gy equivalent to the area of concern. After radiation
therapy, the visual acuity and the right visual ﬁeld defect
and optic nerve pallor stabilized, whereas the left temporal
visual ﬁeld defect disappeared. One year after completion
of the proton therapy, cranial MRI showed resolution of the
suprasellar mass, thickening of the optic chiasm without
deﬁnite residual tumor, and a still absent posterior pituitary
bright spot (Fig. 1c). Anterior and posterior pituitary
function never recovered.
Methods and results
Recognition of pituitary antigens
by immunoﬂuorescence
The patient’s serum was tested for the presence of pituitary
antibodies by indirect immunoﬂuorescence, using Macaca
mulatta pituitary as the substrate [17]. No pituitary anti-
bodies were found using this method (data not shown),
which is known to have low sensitivity and speciﬁcity [18].
Recognition of pituitary and systemic antigens
by immunoblotting
To increase the sensitivity of pituitary antibody detection,
the patient’s serum was reacted against normal human
pituitary cytosolic proteins, separated by 2-dimensional
(2D) gel electrophoresis and blotted onto nitrocellulose
membranes as described [17]. The membranes of three pH
ranges (4–5, 5–6, and 6–7) were incubated overnight with
the patient’s serum diluted 1:100, and the antibody binding
detected by chemiluminescence as described [17]. After
exposure of the ﬁlm, the membranes were stripped and
incubated in the same fashion with the sera of a known
patient with primary AH. Unique protein spots recognized
by the germinoma patient were excised from the gel,
digested with trypsin, and sequenced using MALDI-TOF
mass spectrometry. The germinoma serum recognized six
unique protein spots not detected by the AH serum, in the
Fig. 1 Cranial MRI images. Sagittal T1 post-contrast images show-
ing the sellar and supra-sellar mass at diagnosis (a), after glucocor-
ticoid treatment (b), and after radiotherapy (c)
390 Pituitary (2011) 14:388–394
123pH ranges from 5 to 6 (Fig. 3c) and 6 to 7 (Fig. 3d). These
spots contained both proteins preferentially expressed in
the pituitary gland, such as growth hormone, and systemic
proteins like the Sjo ¨gren’s syndrome autoantigen B (La
autoantigen) (Table 1). Accuracy of mass spectrometry
identiﬁcation was conﬁrmed by 1-dimensional gel elec-
trophoresis and immunoblotting using a recombinant
La protein (Fig. 4). The patient’s serum recognized the
Fig. 2 Pituitary histopathology.
a Frozen section of the pituitary
biopsy showing a marked
mononuclear cell inﬁltration of
the anterior pituitary. b A pan-B
cell staining (CD79) shows the
heavy inﬁltrate of B
lymphocytes (similar pattern
was obtained using CD3 for T
lymphocytes, data not shown).
c H&E staining of the formalin-
ﬁxed pituitary biopsy, showing
a few germinoma cells (inset).
d c-Kit staining clearly
highlights the germinoma cells
Fig. 3 2-D gel electrophoresis
and immunoblotting. Panels a
and b represent the Coomassie
blue staining of 2-D gels
prepared from human pituitary
cytosolic proteins, in the pH
range from 5 to 6 (a) and 6 to 7
(b). c, d Show the
corresponding immunoblotting,
after the gels were transferred to
nitrocellulose membranes and
probed using the serum from the
germinoma patient
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123Sjo ¨gren syndrome La protein (lanes 3, 4, and 5), similarly
to the serum of a patient with systemic lupus erythematosus
known to have La autoantibodies (lane 1).
Recognition of germinoma cell antigens by
immunohistochemistry
Once the diagnosis of germinoma was established, we
asked whether germinoma cells were antigenic and rec-
ognizable by the patient’s own antibodies. We thus incu-
bated the patient’s serum with the patient’s pituitary gland
biopsy. Pituitary sections (3 lm-thick) prepared from the
formalin biopsy were deparafﬁnized, re-hydrated, and
incubated with hydrogen peroxide to block endogenous
peroxidase activity. Sections underwent microwave antigen
retrieval in a 0.1 mmol/L citrate buffer for 18 min, and
then overnight incubation at 4C with undiluted patient’s
serum. After proper washing, sections were treated for 1 h
at room temperature with a biotinylated goat anti-human
IgG (diluted 1:500, Jackson Immunoresearch), and
then with peroxidase-labeled streptavidin. Sections were
ﬁnally developed with 3-30-diaminobenzidine (Sigma,
USA) chromogen, and counterstained with hematoxylin. In
addition to the expected strong staining of the numerous
IgG-producing plasma cells that inﬁltrated the patient’s
pituitary, the patient’s serum also recognized antigens
expressed on the membrane and cytoplasm of the large
neoplastic germinoma cells (Fig. 5).
Discussion
The present case report emphasizes the difﬁculties some-
times encountered in establishing the correct etiology of
non-functioning pituitary masses. These masses share
similar clinical presentations and radiological ﬁndings, and
often a similar natural history. In both sellar germinomas
and AH, in fact, the hypopituitarism can precede for years a
visible pituitary mass [8, 19], so that prolonged symp-
tomatic periods prior to diagnosis are common [2].
In addition to the similarities indicated above, germino-
mas and AH can share similar pathological ﬁndings. AH is
characterized pathologically by a diffuse inﬁltration of the
pituitary gland with mononuclear cells, predominantly
lymphocytes, which disrupt the normal acinar architecture
and destroy the endocrine cells. A similar lymphocytic
inﬁltrationcanalsobeseeningerminomas,andsometimesit
is so marked to render the identiﬁcation of the neoplastic
germinomacellsverychallenging.Itisthereforenotunusual
forintrasellargerminomastobemisdiagnosedasAH[9,20].
Germinomas are highly immunogenic tumors, showing
perhaps the highest degree of tumor inﬁltrating lymphocytes
among human neoplasias. Tumor inﬁltrating lymphocytes
have been characterized by immunohistochemistry [21], and
are known to favorably affect the clinical outcome of germi-
nomas [5, 22]. Tumor inﬁltrating lymphocytes are present
independentlyoftheanatomiclocationofthegerminoma[23]
and despite a low or absent expression of major histocom-
patibility class I molecules [24].
The reason for this rich lymphoid inﬁltrate in germi-
nomas, however, remains unknown. We postulated that
germinoma cells express a variety of antigens, some of
which are never seen by the host immune system, and thus
Fig. 4 1-D gel electrophoresis and immunoblotting. The gel showed
that the germinoma patient’s serum recognized La recombinant
protein (added in decreasing concentration from lane 3 to 5). Lane 1
is the positive control using the serum from a lupus patient known to
have La autoantibodies
Fig. 5 Immunohistochemistry performed using the patient’s own
pituitary biopsy and serum. The serum contains antibodies that
recognize the large germinoma tumor cells (arrow), among the heavy
lympho-plasmacytic inﬁltrate
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123capable of initiating a polyclonal immune response. In
keeping with this hypothesis, we showed that the patient’s
germinoma cells, located within her pituitary gland, were
recognized by the patient’s own serum, indicating the
existence of germinoma-speciﬁc autoantigens. The
patient’s serum also contained autoantibodies recognizing
numerous proteins present in the pituitary. Some proteins,
like growth hormone, were restricted to the pituitary gland,
thus indicative of pituitary-speciﬁc autoimmunity. Other
proteins, like the La autoantigen, were systemic and
detected in the absence of signs or family history of Sjo ¨-
gren syndrome. This ‘‘aberrant’’ and broad antigenic rec-
ognition could represent an early event in the pathway
leading to the recruitment of tumor inﬁltrating lymphocytes
by germinoma cells. Once homed to the germinoma site,
the immune response could then spread to the organ/tissue
harboring the germinoma (the pituitary gland in this case),
secondarily causing organ-speciﬁc abnormalities (hypopi-
tuitarism in our patient).
In summary, we report a case of intra- and supra-sellar
germinoma initially misdiagnosed as AH, and provide
insights to explain the lymphocytic inﬁltration typically
seen in germinomas.
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